| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 9,081,426 | 9,086,748 | 8,739,350 | 9,149,803 | | Cost of Revenue | 7,334,067 | 7,324,162 | 7,102,274 | 7,399,690 | | | Gross Profit | 1,747,359 | 1,762,586 | 1,637,076 | 1,750,113 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,250,031 | 1,222,314 | 1,231,753 | 1,328,249 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 497,328 | 540,272 | 405,323 | 421,864 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,012 | 3,395 | 3,514 | 5,223 | | Earnings Before Interest And Taxes | 499,340 | 543,667 | 408,837 | 427,087 | | Interest Expense | 33,800 | 33,279 | 28,233 | 28,400 | | Income Before Tax | 465,540 | 510,388 | 380,604 | 398,687 | | Income Tax Expense | 139,335 | 195,074 | 154,438 | 161,033 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 326,205 | 315,314 | 226,166 | 237,654 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 326,205 | 315,314 | 226,166 | 237,654 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $326,205 | $315,314 | $226,166 | $237,654 |
|
2.03% Nasdaq 0.00%
Income Statement
